Suppr超能文献

通过基于几何的采样和引导分子动力学探究表没食子儿-3-没食子酸酯对突变型(L84F)超氧化物歧化酶1蛋白毒性聚集体的抑制活性。

Probing the inhibitory activity of epigallocatechin-gallate on toxic aggregates of mutant (L84F) SOD1 protein through geometry based sampling and steered molecular dynamics.

作者信息

Srinivasan E, Rajasekaran R

机构信息

Bioinformatics Lab, Department of Biotechnology, School of Bio Sciences and Technology, VIT University, Vellore 632014, Tamil Nadu, India.

Bioinformatics Lab, Department of Biotechnology, School of Bio Sciences and Technology, VIT University, Vellore 632014, Tamil Nadu, India.

出版信息

J Mol Graph Model. 2017 Jun;74:288-295. doi: 10.1016/j.jmgm.2017.04.019. Epub 2017 Apr 20.

Abstract

Amyloid formation and protein aggregation are considered to be at the core of the disease pathology for the various neurodegenerative disorders such as Amyotrophic lateral sclerosis (ALS). Considerable experimental reports have suggested that epigallocatechin-gallate (EGCG), a natural polyphenol from the green tea inhibits the amyloid formation in multiple neurodegenerative disease. Mutations in SOD1 protein are considered to a key factor that contributes towards the rapid disease progression and the pathogenesis in both, the sporadic and familial form. In our study, we computationally examined the inhibitory action of EGCG against the native and the mutant SOD1 through molecular docking, steered molecular dynamics and conformational sampling methods From the outcome, we could conjecture that the protein destabilization and increased β-sheet propensity that occurred due to mutation were regained upon the binding of EGCG. Moreover, the concepts of the free energy landscape analysis are introduced to establish the visual appearance of protein aggregation upon mutation. Altogether, we come to know that the binding of EGCG on mutant SOD1 has reduced the formation of the toxic aggregates upon mutation. Hence, our study could be an initiative in deciphering the inhibitory action of EGCG against the aggregated mutant SOD1, which could be a therapeutic potential against the treatment for the incurable neurodegenerative disorder (ALS) affecting the mankind.

摘要

淀粉样蛋白形成和蛋白质聚集被认为是诸如肌萎缩侧索硬化症(ALS)等各种神经退行性疾病病理的核心。大量实验报告表明,表没食子儿茶素没食子酸酯(EGCG),一种来自绿茶的天然多酚,可抑制多种神经退行性疾病中的淀粉样蛋白形成。SOD1蛋白中的突变被认为是导致散发性和家族性形式疾病快速进展和发病机制的关键因素。在我们的研究中,我们通过分子对接、引导分子动力学和构象采样方法,从计算上研究了EGCG对天然和突变型SOD1的抑制作用。从结果来看,我们可以推测,由于突变而发生的蛋白质不稳定和β-折叠倾向增加,在EGCG结合后得以恢复。此外,引入了自由能景观分析的概念,以建立突变后蛋白质聚集的可视化外观。总之,我们了解到EGCG与突变型SOD1的结合减少了突变后有毒聚集体的形成。因此,我们的研究可能是解读EGCG对聚集的突变型SOD1抑制作用的一项举措,这可能具有治疗影响人类的无法治愈的神经退行性疾病(ALS)的潜力。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验